NeoGenomics Inc (NEO)
14.01
-0.13
(-0.92%)
USD |
NASDAQ |
Nov 05, 11:37
NeoGenomics Profit Margin (Quarterly): -11.33% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -11.33% |
| March 31, 2024 | -17.32% |
| December 31, 2023 | -9.21% |
| September 30, 2023 | -12.19% |
| June 30, 2023 | -16.56% |
| March 31, 2023 | -22.44% |
| December 31, 2022 | -16.36% |
| September 30, 2022 | -28.62% |
| June 30, 2022 | -28.23% |
| March 31, 2022 | -42.17% |
| December 31, 2021 | -33.21% |
| September 30, 2021 | -16.77% |
| June 30, 2021 | 62.33% |
| March 31, 2021 | -19.14% |
| December 31, 2020 | 12.24% |
| September 30, 2020 | 2.04% |
| June 30, 2020 | -7.85% |
| March 31, 2020 | -6.58% |
| December 31, 2019 | 5.89% |
| September 30, 2019 | 2.05% |
| June 30, 2019 | 1.96% |
| March 31, 2019 | -2.54% |
| December 31, 2018 | 0.46% |
| September 30, 2018 | 2.93% |
| June 30, 2018 | -0.56% |
| Date | Value |
|---|---|
| March 31, 2018 | 1.02% |
| December 31, 2017 | 7.40% |
| September 30, 2017 | -7.21% |
| June 30, 2017 | 0.78% |
| March 31, 2017 | -2.03% |
| December 31, 2016 | -13.78% |
| September 30, 2016 | -0.11% |
| June 30, 2016 | 0.65% |
| March 31, 2016 | 0.26% |
| December 31, 2015 | -5.40% |
| September 30, 2015 | -0.50% |
| June 30, 2015 | -0.72% |
| March 31, 2015 | -3.30% |
| December 31, 2014 | 4.19% |
| September 30, 2014 | -1.25% |
| June 30, 2014 | 1.33% |
| March 31, 2014 | 0.56% |
| December 31, 2013 | 4.68% |
| September 30, 2013 | 5.33% |
| June 30, 2013 | 1.75% |
| March 31, 2013 | 0.02% |
| December 31, 2012 | -0.76% |
| September 30, 2012 | -6.87% |
| June 30, 2012 | 3.53% |
| March 31, 2012 | 3.98% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-42.17%
Minimum
Mar 2022
62.33%
Maximum
Jun 2021
-10.81%
Average
-16.36%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 25.86% |
| Hologic Inc | 19.23% |
| Ekso Bionics Holdings Inc | -50.18% |
| T2 Biosystems Inc | -459.2% |
| CEL-SCI Corp | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.38% |
| Return on Assets | -4.71% |
| Return on Invested Capital | -5.32% |
| Gross Profit Margin (Quarterly) | 44.07% |
| Operating Margin (Quarterly) | -12.40% |
| Return on Net Operating Assets | -6.26% |